2m 2m 2m 2m 2m 2m 2m
Madrigal Pharmct (MDGL)
NASDAQ
$499.49-$0.22 (-0.04%)
Price as of Oct 02, 2026 4:18 PM EDT- $11.5BMarket Cap
- 11.14%1-Year Change
- BiotechnologyIndustry
Madrigal Pharmct (MDGL)
$499.49-$0.22 (-0.04%)
MDGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $499.71 | ||
Change | -$4.25 (-0.84%) | ||
Open | $502.28 | ||
High | $510.00 | ||
Low | $497.73 | ||
Previous Close | $503.96 | ||
Volume | 204,564 | ||
30-Day Average Volume | 224,423 | ||
1-Week Change | -2.63% | ||
1-Month Change | -7.24% | ||
1-Year Change | 11.14% | ||
3-Year Change | 242.17% | ||
5-Year Change | 521.14% | ||
Fundamentals | |||
Shares Outstanding | 23.1M | ||
Total Assets | $1.2B | ||
Market Cap | $11.5B | ||
Enterprise Value | $11.6B | ||
Period: QTR TTM FY | |||
Revenue | $364.3M | ||
Net Income | -$57.9M | ||
Free Cash Flow | $19.1M | ||
EBIT | -$57.9M | ||
EBITDA | -$57.6M | ||
Net Working Capital | $825.0M | ||
EPS | -$1.99 | ||
Enterprise Value/EBITDA | -201 | ||
Enterprise Value/Revenue | 32 | ||
P/B | 22 | ||
P/E | -251 | ||
PEG | -6 | ||
Price/Free Cash Flow | 605 | ||
Price/Operating Cash Flow | 495 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 07/25/2016 | ||
Earnings & Revenue